dRTA in SS may result from autoimmune targeting of distal nephron transporters such as H+-ATPase and anion exchanger 1. Early recognition and supportive treatment are essential to prevent complications including nephrolithiasis, progressive kidney dysfunction, and life-threatening hypokalemia. Here, SLC4A1 is linked to nephrolithiasis.